The pissheads in online communities are barking again.
“I heard if you use EPO, your blood vessels get blocked and you die. Is that true?”
The moment they utter that question, they’re already a corpse in the trenches of the chemical battlefield.
Infantry who only look at a weapon’s lethality and fail to grasp its tactical value.
That’s their level.
That incident where an Australian Olympia bodybuilder died from pulmonary embolism?
That’s proof that the weapon, EPO, wasn’t the killer, but the commander wielding it was a moron.
Most guys still understand EPO as just a blood doping agent for endurance athletes.
They are trapped in that narrow frame of thinking of it as supplies that increase oxygen transport.
But those who stop at that level are already destined to be weeded out in this game.
EPO is not a simple fuel enhancer.
This is an air support unit that dominates all variables on the battlefield, a navigation system that directly upgrades the pilot’s brain.
While you’re trembling, only looking at blood concentration and viscosity, the real dominators are hacking the entire nervous system and recovery system using EPO’s dual functions.
The war has already begun.
But you still don’t even know how to dig a trench while shoveling.
EPO, Erythropoietin.
On the surface, it might seem like a simple command for red blood cell production, but in reality, it’s a special operations agent simultaneously commanding two fronts.
First Mission, Erythropoiesis.
This is the face of EPO that everyone knows.
When EPO secreted by the kidneys locks onto the bone marrow, the red blood cell production line goes into full operation.
The number of troops carrying oxygen, i.e., red blood cells, increases explosively, and the Hematocrit (HCT) level soars.
The goal is simple.
To maximize oxygen supply to the allied outpost called muscle, pushing combat endurance capability to its limit.
This mission is executed by binding to the EPO receptor (EPOR) and activating the JAK-2/STAT-5 signaling pathway.
But the real tactical value lies hidden in the second mission.
Second Mission, Tissue Protection.
This is EPO’s hidden face, the blade that separates the high-level from the low-level.
While EPO binds to alternative receptors like the common beta chain receptor (BCR) or CRLF3, in addition to EPOR, it carries out a completely different mission.
This pathway, unrelated to hematopoiesis, protects and regenerates tissues throughout the body, including the brain, heart, and muscles.
This is not simple defense.
This is a system upgrade.
In the brain, it blocks neural cell damage through antioxidant and anti-inflammatory actions, while simultaneously promoting the generation of new neurons to increase brain plasticity.
Simply put, it’s like installing a cooling system on an overheated Central Processing Unit (CPU), turning on self-repair functions, and overclocking its performance.
EPO’s true value lies in its ability to maintain sharper and clearer judgment, not a brain fogged by carbohydrate depletion late in the season.
Amateurs tremble in fear of blood clots, only looking at HCT levels, but a tactician dismisses HCT as a variable to be managed.
The target is below HCT 52%.
The ability to control it without crossing this line is the qualification to wield this weapon.
Bodybuilder ‘H’.
8 weeks left in the season, weight 105kg, a classic physique bodybuilder competitor.
He had already reached his limit.
Training volume was at its peak, calories were at rock bottom, his CNS screamed every day, and muscle soreness wouldn’t fade due to poor recovery.
Even when he woke up in the morning, the fog in his head wouldn’t clear.
It was a typical frontline situation right before burnout.
At this moment, the order to administer EPO was given to “H”.
Phase 1: Initial Infiltration (Weeks 1-2)
Operation Name: Low-Dose Infiltration and Response Observation.
Deployed Forces: Epoetin Alfa 1,000iu, subcutaneous injection 3 times per week.
Engagement Record: Pre-administration HCT level 44%.
After 2 weeks, increased to 47.5%.
“H” reported that his recovery speed between sets improved dramatically.
It was as if he had gained a second heart, allowing him to push through the last 2-3 reps.
No distinct changes in the nervous system were observed yet.
Phase 2: Firepower Enhancement & Risk Management (Weeks 3-5)
Operation Name: Effective Strike and Side Effect Control.
Deployed Forces: Increased to 1,500iu, maintained 3 times per week.
Low-dose Aspirin (81mg) administered daily.
Engagement Record: Week 5, HCT 51.8%.
Approaching the critical point.
“H” reported mild headaches and elevated blood pressure.
Immediate tactical adjustment.
Reduced EPO dosage to 1,000iu and performed therapeutic phlebotomy once a week, removing 300cc of blood.
HCT stabilized at 49%.
From this point on, “H” reported dramatic changes.
“My head cleared up. My sleep quality changed, and post-training fatigue was cut in half.”
Finally, EPO’s neuroprotective and tissue recovery functions were fully activated.
Phase 3: Operation Completion & Withdrawal (Weeks 6-8)
Operation Name: Maximum Effect Maintenance and Safe Retreat.
Deployed Forces: Reduced to 1,000iu, 2 times per week.
Engagement Record: “H” maintained optimal condition and cognitive ability right up to the competition.
Blood viscosity was perfectly controlled, and muscle pump and recovery were at their peak throughout the season.
In contrast, former athlete B, who used EPO uncontrollably, hit HCT 58% and blew his season due to deep vein thrombosis in his leg.
The weapon was the same, but the commander’s capability decided between survival and ruin.
This protocol is not some simple guide.
It’s the rules of engagement for surviving the battlefield.
Especially considering the reality of domestic hospital accessibility and cost, it’s the most practical tactic.
Protocol Summary
Phase 1: Pre-Operation Intelligence Gathering
Mandatory blood test before starting the cycle.
CBC (including RBC, Hemoglobin, Hematocrit), Iron Panel (including Ferritin).
Initiating an operation without baseline data is suicide.
Phase 2: Low-Dose Infiltration & Adaptation
Dosage: Epoetin Alfa 1,000~1,500iu, subcutaneous injection 2~3 times per week.
Duration: Total 6~8 weeks.
This is a weapon for short-term concentrated strikes, not a long-term garrison.
Target: Enter the HCT 48~50% range.
Phase 3: Real-Time Monitoring & Response
Essential Monitoring: Track HCT via CBC every 2 weeks.
Danger Threshold: HCT 52%.
Counter Tactics:
-Reduce Firepower: Decrease EPO dosage by 20~30%.
-Viscosity Management: Consider administering low-dose Aspirin (81mg/day).
-Force Reduction (Last Resort): If HCT exceeds 53%, immediately perform therapeutic phlebotomy (blood donation).
Utilizing blood donation centers is the most practical option domestically.
Phase 4: Advanced Tactics
Top-tier tacticians target only the tissue protection effects without the hematopoietic risk.
Non-hematopoietic derivatives like Carbamylated EPO (CEPO) are that weapon.
They maximize neuroprotection and tissue regeneration without raising HCT.
However, they are nearly impossible to obtain domestically, and the cost is astronomical.
This is a future weapon accessible only to a very select few for now.
Most bodybuilders still see EPO only as an oxygen transport tool.
A low-level way of thinking that only focuses on muscle.
But the real battle starts in the brain.
If the central nervous system collapses, any powerful muscle is just a sandcastle.
EPO’s true value lies not in the blood, but in its ability to dominate the nerves and tissues.
Increased red blood cells are merely a means.
The real goal is to take control of the entire recovery system and command the battlefield until the end while maintaining peak cognitive state.
Anyone can build a body.
But only those who dominate the system survive to become legends in the end.
The moment you understand that difference, you are no longer infantry, but a commander.
Relevant Core Research Papers
1.Erythropoietin as a Neuroprotective Molecule: An Overview of Its Mechanisms
EPO exhibits neuroprotective effects by inhibiting neuroinflammation, oxidative stress, and cell death.
Link: https://pubmed.ncbi.nlm.nih.gov/31450955/
2.Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain injury
EPO exerts neuroprotective mechanisms through EpoR activation and contributes to identifying new therapeutic targets.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC5649449/
3.Erythropoietin and its derivatives: from tissue protection to immune modulation
EPO and its derivatives have tissue protective and immune modulatory functions, acting through EPO receptors and the common beta chain receptor.
Link: https://www.nature.com/articles/s41419-020-2276-8
4.Reflections on Neonatal Erythropoietin Neuroprotection Studies
EPO exhibits neuroprotective effects, but its efficacy may vary depending on dose and treatment duration.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC4529536/
5.Erythropoietin monotherapy for neuroprotection after neonatal encephalopathy
EPO monotherapy exhibits neuroprotective effects, with safety and efficacy demonstrated at various doses.
Link: https://pubmed.ncbi.nlm.nih.gov/34175900/
